In this month of February I will discuss the three hottest stocks to purchase this month. These are and Pfizer, L Brands, and LVMH Moët Hennessy Louis Vuitton.
Starting off with Pfizer (PFE) the stock has been trading sideways for three years because of staggering revenue growth and, with the familar trend of other successful pharma firms, faces pressure political to lower their prices. This is proven due to the fact that trades have been only 11 times forward earnings and yields 4%s. This has caused a lot of negative feedback.
Next is L Brands (LB). L Brands is the parent company of Victoria’s Secret has struggled in recently as customers has changed to cheaper and more competition in the Internet. However, Victoria’s Secret is head in its market space which makes the stock relatively stock. The stock trades at the 2013 stocks and prices with a yielded dividend over 4%. Also, Victoria’s Secret many years of experience in direct-to-consumer catalogue sales. The firm’s marketing has been stale somewhat, but revenues have risen since the 2008-2009 recession. At present prices, a person will be paid very well when the marketing reboot occurs.
Lastly, LVMH Moët Hennessy Louis Vuitton (LVMUY), the world’s greatest fashion powerhouse… and also happens to be the maker of great champagne. So if anything gets February off to a proper start, it would be a nice bottle of Dom Perignon and a designer purse for that special lady. Back to business, European stocks have mostly traded sideways for years, and LVMH is no exception. This stock causes the euro to bounce on European stocks generally, and on an recovery in China, the world’s largest luxury consumer. This stock is not exactly cheap, trading at about 23 times earnings, but this is also a stock that has traditionally traded at a premium. You’re get a healthy 2% dividend while waiting for the upsing to happen.